繁 简 About Us Company Profile Corporate Structure Milestones Core Business R&D and Production Base Zhuhai R&D and Production Base Kunming R&D and Production Base Global Sales Network Chinese Medicine Development Chinese Medicine R&D Chinese Medicinal Materials Decoction Slices Biomedical Technology and Products Tianda Products Pipeline Quality Healthcare Services Investor Relations Corporate Information Corporate Governance Announcements & Circulars Financial Statements Shares and Details Investor Calendar Investor Enquiries Email Alerts Notices (Replacement of Lost Share Certificates) Dissemination of Corporate Communications Sustainability Our Sustainable Development ESG Report Careers Wort At Tianda Recruitment Vacancies Internship Programmes Trainee Programmes Media Centre Press Releases Media Coverage Contact Us 2019 Select Year 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 02.12.2019 天大藥業(00455)加碼中藥産業 淨利潤同增4.2%(Chinese version only) (Zhitong Caijing) 28.11.2019 天大藥業(00455)中期股東應佔溢利增4.2%至260.57萬港元(Chinese version only) (Zhitong Caijing)
